This HTML5 document contains 202 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1593/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37478631
rdf:type
wikibase:Item
schema:description
სამეცნიერო სტატია 2009年學術文章 مقالهٔ علمی научна статия teaduslik artikkel article scientific wissenschaftlicher Artikel 2009年学术文章 บทความทางวิทยาศาสตร์ naučni članak سائنسی مضمون 2009年学术文章 tudományos cikk գիտական հոդված 2009年学术文章 scienca artikolo наукова стаття, опублікована в грудні 2009 articolo scientifico artykuł naukowy artigo científico (publicado na 2009) artikulong pang-agham 2009年學術文章 artigo científico (publicado na 2009) vitskapeleg artikkel 2009年學術文章 articol științific научни чланак مقالة علمية نشرت في ديسمبر 2009 επιστημονικό άρθρο vetenskaplig artikel videnskabelig artikel (udgivet 2009) 2009年學術文章 artículu científicu espublizáu en 2009 article scientifique (publié 2009) vitenskapelig artikkel мақолаи илмӣ scientific article published on December 2009 научная статья vedecký článok artigo científico 2009年の論文 tieteellinen artikkeli научни чланак מאמר מדעי article científic 2009年学术文章 2009年學術文章 vědecký článek 2009年學術文章 artikull shkencor bài báo khoa học artículo científico publicado en 2009 2009 nî lūn-bûn мақолаи илмӣ ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ mokslinis straipsnis 2009年学术文章 bilimsel makale 2009년 논문 wetenschappelijk artikel
p:P577
wds:Q37478631-C2D384A1-536E-4771-A17C-EC06456C47EE
wdt:P577
2009-12-01T00:00:00Z
p:P2860
wds:Q37478631-0F423473-1021-40CE-9C03-F7CBCA1894AA wds:Q37478631-03BF36FF-2148-4444-99A9-05509568CD60 wds:Q37478631-060CE9FE-B763-4927-AB59-E8F8529F9F81 wds:Q37478631-07FD87A3-0C2D-4B73-9B86-97181CBD63F7 wds:Q37478631-087E903E-F1BF-41A3-BE82-18D912005AB7 wds:Q37478631-2CC799C5-4AA8-4736-A94C-7F571870F20F wds:Q37478631-31B91453-52F9-41F6-9BC9-A022F64A31A4 wds:Q37478631-32CD2A90-C01A-4C92-B0F1-4F813B46CC3D wds:Q37478631-332D00F5-F855-4F17-8FF5-FDA9911A82BA wds:Q37478631-165852BF-08E2-49D0-B494-A25DD09D17D7 wds:Q37478631-21699210-D453-4025-A3CE-F5BB21CDFD08 wds:Q37478631-27F57D68-24D5-4D6F-8852-69CD28D167A4 wds:Q37478631-CA1A62AB-962C-4BB9-87D7-CB816FB5899B wds:Q37478631-CEAC0AEE-FCE0-475A-AAFD-A1BFAD2DEABE wds:Q37478631-D466F328-DEA5-40D1-A251-2403E9D9B186 wds:Q37478631-BBB869AC-C366-4006-B081-C38596273D06 wds:Q37478631-C63F9260-0706-4920-9902-A20C9AF3F564 wds:Q37478631-C8214985-F8BA-4D78-8DE1-6A59F22FE898 wds:Q37478631-F648310B-E6EC-4F92-A005-8E175AECB823 wds:Q37478631-DDD411E3-ECE5-4387-BD7E-6A56F079BEB9 wds:Q37478631-DEBC2E5B-34BF-428E-91FB-0E4F5208F842 wds:Q37478631-EE2918EA-772F-4630-BF4F-6189872FD05C wds:Q37478631-9E65BCB6-5689-4B42-A1E7-48312D56B715 wds:Q37478631-9E99A3BE-6897-4E80-A51E-FB888CE27D69 wds:Q37478631-A1EEFCF6-DB14-4BF5-9C79-BD8DEEFD68F5 wds:Q37478631-A4DBC784-BD4B-456E-85C4-074A959BD3F3 wds:Q37478631-7E205F53-EAAF-4331-B54A-AE21E8B12824 wds:Q37478631-96B1C0E2-9433-4783-ACD4-D0E82B54CA97 wds:Q37478631-9CF630F7-607D-488C-8CE1-0CE849475B6F wds:Q37478631-B3EFAFDA-57D5-4D12-8C67-E588644E9A7E wds:Q37478631-B3F1BEC8-5EFD-4423-91E8-9732D3B56E73 wds:Q37478631-B80E6C00-ABC2-4A23-97E9-CFD5F23C5F01 wds:Q37478631-BB5D00F6-F0D1-4BE2-AB59-04D70829516A wds:Q37478631-A93A8EDE-782B-4FE4-BBB2-D9CB52B53AA7 wds:Q37478631-A9CC81F3-05A9-4FDD-A4EA-9E46C0FEC102 wds:Q37478631-ACA35E96-F979-4D87-BD2C-A23B78B3892E wds:Q37478631-FD3738CE-E2D7-43A7-A5EF-09A328DA358A wds:Q37478631-4034C9C9-FCD4-45DE-A70F-8FCB010DE7F8 wds:Q37478631-4532C4F1-67C8-4309-A1A2-E6392BCC4A92 wds:Q37478631-4EED9A54-0644-4D26-969D-D27C4D6B0E3A wds:Q37478631-372FA309-D926-4F5C-94D4-87C2506A2B7D wds:Q37478631-3CEACFA2-8831-4C09-A357-DC3E62BA6D30 wds:Q37478631-3D9971FD-9D9E-41D7-8E8C-B79D5EC1B122 wds:Q37478631-6645B709-926B-4072-BEC6-AC4E15C0C779 wds:Q37478631-722E34FB-63B9-403E-A8F6-172665623EE5 wds:Q37478631-777C1728-3136-41F6-A1E9-6E6DE98D447D wds:Q37478631-5416BC1B-AA90-4157-A95F-D277585ABFBA wds:Q37478631-565E1545-6C49-4BAD-B4A5-CB52789BDCAD wds:Q37478631-5A226E04-AFC9-40E1-A627-235B2F1C1B5B wds:Q37478631-0B1CB477-0DC6-419F-A40A-C53D29A2DB39
wdt:P2860
wd:Q27860902 wd:Q24338582 wd:Q29618101 wd:Q79562632 wd:Q29617779 wd:Q28327651 wd:Q40440700 wd:Q35610867 wd:Q36918692 wd:Q24300915 wd:Q44532391 wd:Q40179972 wd:Q34553801 wd:Q32046208 wd:Q36380591 wd:Q54322682 wd:Q46711950 wd:Q29614174 wd:Q28239257 wd:Q29617748 wd:Q40398965 wd:Q28278893 wd:Q35753167 wd:Q24682697 wd:Q39972651 wd:Q35930365 wd:Q35082684 wd:Q56772657 wd:Q24329244 wd:Q46606786 wd:Q36979047 wd:Q24597817 wd:Q46629675 wd:Q28567006 wd:Q42160057 wd:Q24633606 wd:Q24302566 wd:Q40730540 wd:Q39945380 wd:Q35932790 wd:Q36174994 wd:Q22241898 wd:Q29614175 wd:Q28272728 wd:Q30312086 wd:Q52670758 wd:Q28302887 wd:Q56777095 wd:Q39963624 wd:Q36181524
rdfs:label
CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells
skos:prefLabel
CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells
schema:name
CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells
p:P50
wds:Q37478631-F62CA165-450D-4A86-A416-BB4935013FB2 wds:Q37478631-1C93FA61-F547-40E2-9533-7A92EC698D29 wds:Q37478631-4A19C88A-C946-4C60-AF7A-52F69413F908
wdt:P50
wd:Q125349577 wd:Q6390246 wd:Q125349269
p:P1476
wds:Q37478631-08B123BF-C3C4-48A6-8D62-0918FD257BE6
wdt:P1476
CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells
p:P304
wds:Q37478631-55F1249D-14D0-45CB-A820-9A90FB63EDC2
wdt:P304
1309-1317
p:P31
wds:Q37478631-F3508C4C-C755-40C8-8471-28701CBF6F1A
wdt:P31
wd:Q13442814
p:P921
wds:Q37478631-34CE6536-ACD3-48F8-ADAC-94DD8CEF2F5E
wdt:P921
wd:Q181257
p:P698
wds:Q37478631-0E28E154-C55E-4281-9F99-DE20E3767682
wdtn:P698
n11:20019839
wdt:P698
20019839
p:P1433
wds:Q37478631-7E9AC904-B92B-47EF-8656-7B41246576AF
wdt:P1433
wd:Q2962042
p:P433
wds:Q37478631-7659964A-88C5-477F-8DE8-49382B82051F
p:P478
wds:Q37478631-AD9BEDFB-7B08-49CB-BD6A-05B6C1D50F38
wdt:P433
12
wdt:P478
11
p:P356
wds:Q37478631-F97BAD80-1954-4872-9970-121DE2CC3D68
wdtn:P356
n10:NEO.09936
wdt:P356
10.1593/NEO.09936
p:P5875
wds:Q37478631-CE317764-2CA7-479E-A294-09CA31AAB6A5
wdt:P5875
40697131
p:P932
wds:Q37478631-EAC9A263-A53A-4CC1-A99E-3B614B44F448
wdt:P932
2794512